Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -1084.23% is 2355% below its 1-year average of -44.16%, near the low end of its 1-year range (-1084.23%–0.00%).
2355.33% below its 12-month average of -44.16%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -220.79%.
NET PROFIT MARGIN
-1084.23%
NET PROFIT MARGIN AVG TTM
-44.16%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-2355.33%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-416911.54%
vs the sector median at left
Ensysce Biosciences, Inc.
Market Cap
$6.61M
Net Profit Margin
-1084.23%
TTM Avg
-44.16%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.57M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.66M
Net Profit Margin
-10978.48%
TTM Avg
-12422.83%
3Y Avg
-10763.38%
5Y Avg
-10131.90%
Market Cap
$6.54M
Net Profit Margin
-84.79%
TTM Avg
-89.20%
3Y Avg
-105.63%
5Y Avg
-91.66%
Market Cap
$6.74M
Net Profit Margin
-611.47%
TTM Avg
-627.26%
3Y Avg
-917.71%
5Y Avg
-6297.45%
Market Cap
$6.28M
Net Profit Margin
-534.27%
TTM Avg
-983.65%
3Y Avg
-1060.24%
5Y Avg
-924.37%
Market Cap
$6.95M
Net Profit Margin
0.00%
TTM Avg
-970.10%
3Y Avg
-487.29%
5Y Avg
1862.33%
Market Cap
$7.00M
Net Profit Margin
-6523.04%
TTM Avg
-4247.49%
3Y Avg
-2263.82%
5Y Avg
-1493.48%
Market Cap
$7.05M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-287.91%
5Y Avg
-676.70%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ensysce Biosciences, Inc. (ENSC) | $6.61M | -1084.23% | -44.16% | 0.00% | 0.00% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.57M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aclarion, Inc. (ACON)vs › | $6.66M | -10978.48% | -12422.83% | -10763.38% | -10131.90% |
| Biomerica, Inc. (BMRA)vs › | $6.54M | -84.79% | -89.20% | -105.63% | -91.66% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.74M | -611.47% | -627.26% | -917.71% | -6297.45% |
| Femasys Inc. (FEMY)vs › | $6.28M | -534.27% | -983.65% | -1060.24% | -924.37% |
| Exicure, Inc. (XCUR)vs › | $6.95M | 0.00% | -970.10% | -487.29% | 1862.33% |
| Co-Diagnostics, Inc. (CODX)vs › | $7.00M | -6523.04% | -4247.49% | -2263.82% | -1493.48% |
| KALA BIO, Inc. (KALA)vs › | $7.05M | 0.00% | 0.00% | -287.91% | -676.70% |
| Mangoceuticals, Inc. (MGRX)vs › | $7.07M | -4791.48% | -2970.23% | -7387.99% | -5910.39% |
Operating Margin
0.0%
Net Profit Margin
-1084.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -220.79% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | -118.65% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
